Son’s love inspires new name for Breakthrough T1D Center of Excellence in New England
The Center has been renamed The Breakthrough T1D Barbara Dewey Cammett Center of Excellence in New England.
The essential role of Advocacy in advancing T1D cell therapies
Breakthrough T1D's Advocacy efforts contribute to clear and efficient policies and secure government funding for manufactured cell therapies.
Celiac disease and type 1 diabetes: What’s the connection?
What is the link between celiac disease and type 1 diabetes? Learn what celiac disease is, how it is treated, and its connection to T1D.
Medical Affairs team kicks off international islet cell therapy workshops at Breakthrough T1D HQ
Breakthrough T1D's Medical Affairs team hosted experts in islet transplantation to discuss a clinical roadmap for manufactured cell therapies.
New Breakthrough T1D publications highlight unmet needs and demographics of the T1D population
Breakthrough T1D recently published two peer-reviewed journal articles. One detailed burdensome unmet needs in the T1D community and identified key steps we can take to meet these needs. The other used real-world data to better understand American T1D demographics and predict changes in the next decade.
Menstrual cycles, hormones, and T1D: What women need to know
Menstrual cycles and type 1 diabetes (T1D) have a lot in common: they can be unpredictable, inconsistent from person to person, and physically challenging. For Women’s Health Month, Breakthrough T1D is taking a closer look at how periods and menopause may influence blood sugar. What happens during the menstrual cycle? Most girls get their first […]
Treating and preventing eye disease with type 1 diabetes
Diabetic eye disease is a troubling reality for many people living with type 1 diabetes, but research is helping reduce the risk of complications.
Balancing mental health and type 1 diabetes
Taking care of your mental health with type 1 diabetes is just as important as managing your blood sugar and taking your insulin.
Cell therapies in clinical trials: Moving the needle forward
Breakthrough T1D believes that novel cell therapies in the clinical pipeline will transform T1D management, and Project ACT is how we’re going to make them a reality.
Could drugs like Ozempic also benefit people with type 1 diabetes?
Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help people with type 1 diabetes.
